Our Healthcare Services team reviews the latest trends and developments shaping the MedSpa industry in their market overview, including areas of focus for investors and PE activity in the sector, as the demand for treatments continues to soar in the US. Karan Garg, Brad Hildebrand, Vitalie Djugostran #medspa #medicalspa #healthcareservices #wellness #dayspa #PE #finance #investmentbanking #financialadvisory
Solomon Partners’ Post
More Relevant Posts
-
We are excited to introduce FutureMeds’ Promis of Progress: The Progress P.A.C.T. Built on 4 pillars: People, Access, Collaboration, and Truth, it is our company promise and guiding philosophy, designed to shape our interactions with patients, clients, partners, and our team. “𝙐𝙣𝙞𝙛𝙮𝙞𝙣𝙜 𝙨𝙞𝙩𝙚 𝙩𝙚𝙖𝙢𝙨 𝙖𝙘𝙧𝙤𝙨𝙨 𝙢𝙪𝙡𝙩𝙞𝙥𝙡𝙚 𝙘𝙤𝙪𝙣𝙩𝙧𝙞𝙚𝙨 𝙪𝙣𝙙𝙚𝙧 𝙤𝙣𝙚 𝙥𝙪𝙧𝙥𝙤𝙨𝙚 𝙝𝙖𝙨 𝙗𝙚𝙚𝙣 𝙖 𝙛𝙤𝙧𝙢𝙞𝙙𝙖𝙗𝙡𝙚 𝙩𝙖𝙨𝙠. 𝙒𝙚’𝙫𝙚 𝙨𝙥𝙚𝙣𝙩 𝙤𝙫𝙚𝙧 𝙩𝙬𝙤 𝙮𝙚𝙖𝙧𝙨 𝙘𝙧𝙚𝙖𝙩𝙞𝙣𝙜 𝙖 𝙫𝙖𝙡𝙪𝙚 𝙨𝙮𝙨𝙩𝙚𝙢 𝙩𝙝𝙖𝙩 𝙖𝙡𝙞𝙜𝙣𝙨 𝙥𝙚𝙧𝙛𝙚𝙘𝙩𝙡𝙮 𝙬𝙞𝙩𝙝 𝙤𝙪𝙧 𝙢𝙞𝙨𝙨𝙞𝙤𝙣 𝙤𝙛 𝙙𝙚𝙡𝙞𝙫𝙚𝙧𝙞𝙣𝙜 𝙛𝙪𝙩𝙪𝙧𝙚 𝙢𝙚𝙙𝙞𝙘𝙞𝙣𝙚𝙨 𝙩𝙤 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨,” added Radoslaw (Radek) Janiak, CEO 𝗣𝗲𝗼𝗽𝗹𝗲 𝗺𝗮𝗸𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 Clinical research depends on the dedication, commitment & compassion of people. 𝗔𝗰𝗰𝗲𝘀𝘀 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗮𝗹𝗹 We believe everyone deserves the opportunity to thrive. 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝘀 Great things come from working together. 𝗧𝗿𝘂𝘁𝗵 𝗯𝘂𝗶𝗹𝗱𝘀 𝘁𝗿𝘂𝘀𝘁 We are committed to fostering an environment that promotes honesty. “𝙄 𝙝𝙖𝙫𝙚 𝙛𝙪𝙡𝙡 𝙘𝙤𝙣𝙛𝙞𝙙𝙚𝙣𝙘𝙚 𝙩𝙝𝙖𝙩 𝙬𝙞𝙩𝙝 𝙩𝙝𝙚 𝙋𝙧𝙤𝙜𝙧𝙚𝙨𝙨 𝙋.𝘼.𝘾.𝙏. 𝙖𝙣𝙙 𝙤𝙪𝙧 𝙩𝙚𝙖𝙢𝙨’ 𝙨𝙪𝙥𝙥𝙤𝙧𝙩, 𝙬𝙚 𝙬𝙞𝙡𝙡 𝙘𝙪𝙡𝙩𝙞𝙫𝙖𝙩𝙚 𝙖 𝙘𝙤𝙢𝙥𝙖𝙣𝙮 𝙘𝙪𝙡𝙩𝙪𝙧𝙚 𝙖𝙩 𝙁𝙪𝙩𝙪𝙧𝙚𝙈𝙚𝙙𝙨 𝙩𝙝𝙖𝙩 𝙘𝙖𝙣 𝙮𝙞𝙚𝙡𝙙 𝙨𝙞𝙜𝙣𝙞𝙛𝙞𝙘𝙖𝙣𝙩 𝙡𝙤𝙣𝙜-𝙩𝙚𝙧𝙢 𝙗𝙚𝙣𝙚𝙛𝙞𝙩𝙨 𝙛𝙤𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨, 𝙥𝙖𝙧𝙩𝙣𝙚𝙧𝙨 𝙖𝙣𝙙 𝙤𝙪𝙧 𝙩𝙚𝙖𝙢,” said Wojciech Szczepanik, Executive VP of Operations #ClinicalTrials #ClinicalResearch
Introducing FutureMeds’ Promise of Progress: The Progress P.A.C.T.
futuremeds.com
To view or add a comment, sign in
-
There is nothing more enjoyable in business than watching teams willingly engage in all activities aimed at strengthening the culture in the organization.
We are excited to introduce FutureMeds’ Promis of Progress: The Progress P.A.C.T. Built on 4 pillars: People, Access, Collaboration, and Truth, it is our company promise and guiding philosophy, designed to shape our interactions with patients, clients, partners, and our team. “𝙐𝙣𝙞𝙛𝙮𝙞𝙣𝙜 𝙨𝙞𝙩𝙚 𝙩𝙚𝙖𝙢𝙨 𝙖𝙘𝙧𝙤𝙨𝙨 𝙢𝙪𝙡𝙩𝙞𝙥𝙡𝙚 𝙘𝙤𝙪𝙣𝙩𝙧𝙞𝙚𝙨 𝙪𝙣𝙙𝙚𝙧 𝙤𝙣𝙚 𝙥𝙪𝙧𝙥𝙤𝙨𝙚 𝙝𝙖𝙨 𝙗𝙚𝙚𝙣 𝙖 𝙛𝙤𝙧𝙢𝙞𝙙𝙖𝙗𝙡𝙚 𝙩𝙖𝙨𝙠. 𝙒𝙚’𝙫𝙚 𝙨𝙥𝙚𝙣𝙩 𝙤𝙫𝙚𝙧 𝙩𝙬𝙤 𝙮𝙚𝙖𝙧𝙨 𝙘𝙧𝙚𝙖𝙩𝙞𝙣𝙜 𝙖 𝙫𝙖𝙡𝙪𝙚 𝙨𝙮𝙨𝙩𝙚𝙢 𝙩𝙝𝙖𝙩 𝙖𝙡𝙞𝙜𝙣𝙨 𝙥𝙚𝙧𝙛𝙚𝙘𝙩𝙡𝙮 𝙬𝙞𝙩𝙝 𝙤𝙪𝙧 𝙢𝙞𝙨𝙨𝙞𝙤𝙣 𝙤𝙛 𝙙𝙚𝙡𝙞𝙫𝙚𝙧𝙞𝙣𝙜 𝙛𝙪𝙩𝙪𝙧𝙚 𝙢𝙚𝙙𝙞𝙘𝙞𝙣𝙚𝙨 𝙩𝙤 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨,” added Radoslaw (Radek) Janiak, CEO 𝗣𝗲𝗼𝗽𝗹𝗲 𝗺𝗮𝗸𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 Clinical research depends on the dedication, commitment & compassion of people. 𝗔𝗰𝗰𝗲𝘀𝘀 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗮𝗹𝗹 We believe everyone deserves the opportunity to thrive. 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝘀 Great things come from working together. 𝗧𝗿𝘂𝘁𝗵 𝗯𝘂𝗶𝗹𝗱𝘀 𝘁𝗿𝘂𝘀𝘁 We are committed to fostering an environment that promotes honesty. “𝙄 𝙝𝙖𝙫𝙚 𝙛𝙪𝙡𝙡 𝙘𝙤𝙣𝙛𝙞𝙙𝙚𝙣𝙘𝙚 𝙩𝙝𝙖𝙩 𝙬𝙞𝙩𝙝 𝙩𝙝𝙚 𝙋𝙧𝙤𝙜𝙧𝙚𝙨𝙨 𝙋.𝘼.𝘾.𝙏. 𝙖𝙣𝙙 𝙤𝙪𝙧 𝙩𝙚𝙖𝙢𝙨’ 𝙨𝙪𝙥𝙥𝙤𝙧𝙩, 𝙬𝙚 𝙬𝙞𝙡𝙡 𝙘𝙪𝙡𝙩𝙞𝙫𝙖𝙩𝙚 𝙖 𝙘𝙤𝙢𝙥𝙖𝙣𝙮 𝙘𝙪𝙡𝙩𝙪𝙧𝙚 𝙖𝙩 𝙁𝙪𝙩𝙪𝙧𝙚𝙈𝙚𝙙𝙨 𝙩𝙝𝙖𝙩 𝙘𝙖𝙣 𝙮𝙞𝙚𝙡𝙙 𝙨𝙞𝙜𝙣𝙞𝙛𝙞𝙘𝙖𝙣𝙩 𝙡𝙤𝙣𝙜-𝙩𝙚𝙧𝙢 𝙗𝙚𝙣𝙚𝙛𝙞𝙩𝙨 𝙛𝙤𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨, 𝙥𝙖𝙧𝙩𝙣𝙚𝙧𝙨 𝙖𝙣𝙙 𝙤𝙪𝙧 𝙩𝙚𝙖𝙢,” said Wojciech Szczepanik, Executive VP of Operations #ClinicalTrials #ClinicalResearch
Introducing FutureMeds’ Promise of Progress: The Progress P.A.C.T.
futuremeds.com
To view or add a comment, sign in
-
IFNA is proud to host a LIVE Q&A with Ryan Obermeier from Evexia Diagnostics. Maximizing the Diagnostic Laboratory Service Line within Your Practice Thursday, November 14th, 2024 at 1 pm ET. Ryan L. Obemeier, Evexia Diagnostics’ Chief Commercial Officer, will discuss steps you can take to maximize your return on diagnostic laboratory services within your practice. Learn how creating standards within your diagnostics service line will prevent decision fatigue and burnout. Understand how healthcare professionals are utilizing program bundles to maximize patient offerings Gain a glimpse into diagnostic laboratory industry trends Register now >> https://lnkd.in/gQxpJpbg #IFNALiveQA #EvexiaDiagnostics #DiagnosticLaboratory #HealthcareInnovation #PracticeManagement #MedicalLaboratories #MaximizeYourPractice #DiagnosticTrends #HealthcareProfessionals #ClinicalExcellence #LabServiceLine #BurnoutPrevention #ProgramBundles #PatientCareOptimization #HealthTech #MedicalEducation #RyanObermeier #HealthcareLeadership #MedicalNetworking #FutureOfHealthcare
To view or add a comment, sign in
-
In the recent edition, Bert J Quint Navigating New Paths in Wound Management, Euro Health Leaders magazine gladly features B.J. Q., the Founder & CEO of DEBx Medical , who is an exploratory leader exemplifying a commitment to disruptive innovation, which aims to address the significant challenges in wound care. Read More: https://cutt.ly/jeDPxxAl #WoundCareInnovation #HealthcareLeadership #WoundManagement #HealthcareInnovation #BertJQuint #AdvancedWoundCare #HealthcareMagazineEurope #EuropeanHealthInsights #EuroHealthLeaders
To view or add a comment, sign in
-
Next in line at #InnovationDublin24 is the “Is Getting Paid Getting Easier?: The Coming of TCET,” moderated by Stephen Levin of Market Pathways: • Tonya Dowd, MPH, EVP, Reimbursement, Value Generation, and Market Access (RVMA), PRIA Healthcare • Mike Carusi, General Partner, Lightstone Ventures • Brian Shields, CEO & Co-Founder, Neurent Medical Even if you are an early-stage company and there is an existing reimbursement code, from day one, you still need to be thinking carefully about your reimbursement strategy. Otherwise you can get burned. What do you do when you realize a new reimbursement code needs to be created for your solution? Our expert panel weighs in. Getting Paid: Investors need to see a clear reimbursement path to do the math. TCET provides some coverage during real world evidence generation, but it doesn’t provide the new pathway to payment we need for emerging technologies. Remain informed on new articles, conference updates and more with our helpful #medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI
To view or add a comment, sign in
-
Do not miss this book, especially if you are considering any kind of procedure! It's life-changing in so many ways.
🌟 As we navigate the dynamic world of medspas, it’s essential to shine a light on the hidden corners of this industry. Our profile on Dr. Katherine Dee dives into her brave and unfiltered expose of the ugly underbelly of unregulated medspa mayhem. With unregulated practices lurking in the shadows, we must prioritize safety and quality. Just like a master artist chooses the finest materials, we should demand the best for our well-being. Let’s cultivate a space where creativity thrives alongside integrity. 🎨✨ Choose wisely, and remember: the masterpiece of patients' health and beauty deserve nothing less than exceptional care. Together, we can elevate standards and inspire trust! 💪💖 Get the full scoop on Dr. Kate Dee's expose, Med Spa Mayhem: https://lnkd.in/gv5SGaVA Glow Medispa #MedspaSafety #QualityCare #MedSpaRegulation
To view or add a comment, sign in
-
We're out and about again. This time at the Diagnostics North East Conference. Events like this are a really important part of our commercial strategy. Not only do they allow us to meet new and existing customers, but they also allow us to meet end users within the healthcare system and ensure we understand their challenges. ##dxneconf24 #ukdiagnostics #invitrodiagnostics #moleculardiagnostics
To view or add a comment, sign in
-
Great to be at #cmosummit360 in Boston and to hear Gary Pisano’s keynote this morning. So many great points, not least the challenge of bringing together two such different worlds; Business and Science. I think that there’s a third arm to this challenge - doing it in such a way that fits best with the day to day needs of those who ultimately receive the medicine - patients. The science and the business model needs to deliver the difference that patients actually want and value, as this is the real win/win and will ultimately increase the asset value hugely. #patientfocus #biopharma #assetvalue #patientinsights #patientengagement Origins - The Patient Focused Specialists RESONANT GROUP
To view or add a comment, sign in
-
A seminal paper that highlights the gap in awareness when it comes to Hidradenitis Suppurativa (HS) and how real-world claims (i.e., real data) sheds light on the likely prevalence of this devastating disease. That is, 2%. Congratulations to the exceptional author list of this paper! #HS
I'm excited to share that Spherix Global Insights' new white paper, 𝘌𝘢𝘳𝘭𝘪𝘦𝘳 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴 𝘢𝘯𝘥 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵: 𝘛𝘩𝘦 𝘒𝘦𝘺 𝘵𝘰 𝘉𝘦𝘵𝘵𝘦𝘳 𝘖𝘶𝘵𝘤𝘰𝘮𝘦𝘴 𝘪𝘯 𝘏𝘪𝘥𝘳𝘢𝘥𝘦𝘯𝘪𝘵𝘪𝘴 𝘚𝘶𝘱𝘱𝘶𝘳𝘢𝘵𝘪𝘷𝘢, is finally out! 🎉 Working with Joseph F. Merola, M.D. MMSc and Alice Gottlieb to dig into strategies to improve patient outcomes—from increased awareness to earlier use of advanced systemics—has been an awesome experience, and we’re thrilled with the insights we’re sharing here. If you’re interested in where HS care is heading take a look! https://lnkd.in/eQn9_C67 #HSawareness #HealthcareInnovation #PatientCare
To view or add a comment, sign in
17,496 followers
CEO at Alpha Aesthetics Partners. Transforming the aesthetics industry and documenting the journey.
6moGreat review. Strong work on a great industry!